The National Cervical Screening Program (NCSP) aims to reduce cervical cancer cases, illness and death in Australia. Cervical screening in Australia 2019 is the last monitoring report for the previous NCSP, presenting key data for women screened using Pap tests between January 2016 and June 2017 (prior to the renewed NCSP from 1 December 2017).
The following data are for women aged 20–69, screened under the previous NCSP.
Cervical cancer cases and deaths were low by international standards
In 2015, 727 women aged 20–69 were diagnosed with cervical cancer, and 140 died from the disease in 2017. This is equivalent to 9 new cases of cervical cancer diagnosed, and 2 deaths, per 100,000 women. These rates are similar to those for previous years.
Both incidence and mortality halved between the introduction of the NCSP in 1991 and the year 2002 and have since remained at 9–10 new cases, and 2 deaths, per 100,000 women.
More than 5 in 10 women participated in cervical screening
Between 1 January 2016 and 30 June 2017, 2,973,370 women participated in cervical screening. This was estimated to be around 54%–56% of women aged 20–69. (This estimate does not include the final 4 months of the previous NCSP and should not be extrapolated for the period 1 January 2016 to 30 November 2017.)
Participation varied across remoteness areas—it was highest in Inner regional areas at 57% and lowest in Very remote areas at 46%. There was a clear association between participation and socioeconomic group—at 50% for women living in the lowest socioeconomic areas and 62% for women living in the highest socioeconomic areas.